ImmunoTargets and Therapy

期刊全称ImmunoTargets and Therapy
涉及主题医学生物内科学遗传学免疫学免疫系统病理化学生物化学癌症免疫疗法疾病抗体癌症研究抗原受体肿瘤科
期刊介绍

ImmunoTargets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered. In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional. As of 1st April 2019, ImmunoTargets and Therapy will no longer consider meta-analyses for publication.

期刊ISSNprint: 2253-1556
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
6.27.2000000
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量44561463127510881612163
被引量487992102598590959937229920861343173
h-Index0
自引率0.00%
涉及的研究领域IMMUNOLOGY-
中科院2025年分区 ?
大类小类TOP期刊综述期刊
2区2区 免疫学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
IMMUNOLOGYESCIQ257/183

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
IMMUNOLOGYESCIQ281/183
期刊主页https://www.dovepress.com/immunotargets-and-therapy-journal
出版商Dove Medical Press
出版国家(地区)United Kingdom
出版语言English
每年出版文章数30
Gold OA文章占比97.96%
原创研究文献占比
(排除综述)
0.00%
SCI收录类型

Emerging Sources Citation Index (ESCI)

Directory of Open Access Journals (DOAJ)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=%5BISSN%5D
平均审稿周期16 Weeks
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈